When Patrick J. Loehrer, MD, first walked the wards of Moi Teaching and Referral Hospital (MTRH) in Kenya in 2004, he encountered a stark contrast. Patients with HIV were receiving coordinated, compassionate care through the fledgling AMPATH partnership. But for patients with cancer, there was little to offer. Many were facing advanced disease without treatment options.
“This trip changed the trajectory of my career.”
By the time of that first visit, Dr. Loehrer was already a nationally respected oncologist. Trained at Indiana University under Dr. Larry Einhorn, he had helped shape modern treatment for germ cell tumors and thymic cancers. He led national clinical trials, co-founded the Hoosier Oncology Group and built collaborative research networks that changed standards of care. Later, as director of the IU Melvin and Bren Simon Cancer Center, he would guide it to designation as Indiana’s only National Cancer Institute-designated Comprehensive Cancer Center, the gold standard in American oncology.
His resume was already extraordinary, but his life’s work was just beginning.
For more than two decades, Dr. Loehrer has helped build AMPATH Oncology into a model of global partnership. What began with approximately 150 cancer patients seen annually at MTRH has grown into a comprehensive program that now sees that many patients daily. The $5.5 million MTRH Chandaria Cancer and Chronic Diseases Centre opened in 2015, offering chemotherapy in a modern suite and now houses one of the few public radiotherapy and brachytherapy units in Kenya.
On April 15, Dr. Loehrer will receive IU’s John W. Ryan Award for Distinguished Contribution to International Programs and Studies from President Pam Whitten for the work that started with that first trip.
Dr. Adrian Gardner, director of the IU Center for Global Health and executive director of the AMPATH Consortium, describes his enormous impact. “His work has not only advanced cancer care globally but has also inspired countless individuals, myself included, to champion the fight for healthcare for all.”
Dr. Loehrer’s commitment has always extended beyond bricks and mortar. Through fellowship programs in gynecologic oncology, pediatric oncology and medical oncology at Moi University, he and his colleagues have trained a generation of Kenyan physicians who now lead departments, national institutes and professional societies. What once required outside expertise is now sustained locally.
Dr. Elias Melly, CEO of the National Cancer Institute of Kenya, said that Dr. Loehrer’s leadership brought life-saving care to underserved regions and changed lives, including his own. “In addition to the thousands of people who are alive today because of Dr. Loehrer, I am one of many Kenyan healthcare leaders who can trace their professional success to the commitment that Dr. Loehrer made a decade ago.”
Dr. Naftali Busakhala, a specialist physician and former director of hematology-oncology at MTRH, recalls the early days when patients were seen in hospice space and basement corridors. He credits Loehrer’s quiet leadership and shared vision. “The partnership that Moi University and Moi Teaching and Referral Hospital have built with Indiana University and the other consortium universities is truly unique because the people in it share a common vision of improving healthcare for all without seeking individual accolades for themselves or their institutions.”
That humility is echoed in the United States. Dr. Satish Gopal, director of the National Cancer Institute’s Center for Global Health, emphasizes how Dr. Loehrer reframed global oncology for a new generation. “Simply put, Dr. Loehrer has changed what it means to have cancer in western Kenya from a likely death sentence to a treatable illness.”
Under Loehrer’s leadership, AMPATH Oncology has expanded screening for breast and cervical cancer, conducted groundbreaking clinical trials, secured millions in extramural funding and helped expand national insurance coverage for cancer care in Kenya. Research is never detached from service. As Dr. Busakhala writes, “The research we do does not sit on the shelf. It’s put to work to improve care for people with cancer.”
Despite accolades that include recently being named a fellow of the American Association for the Advancement of Science, receiving the American Society of Clinical Oncology (ASCO) Humanitarian Award and leadership roles with the National Cancer Institute and the Lancet Oncology Commission, Dr. Loehrer remains anchored in purpose. He often quotes Mark Twain who said, "The two most important days in your life are the day you are born and the day you find out why."
Kenya was where he found his why.
Dr. Loehrer said that the recognition in John Ryan’s name is personally meaningful, but reflects a collective effort. “This is an honor bestowed on all of those with whom I have worked and with whom I share in a dream of trying ‘to make a difference.’ An honor that perhaps one day would be mentioned in my eulogy.”
The John W. Ryan Award honors a career that moved beyond achievement to impact, beyond titles to transformation, and beyond borders to build enduring hope where there once was none.
Dr. Pat Loehrer in front of the MTRH Chandaria Cancer and Chronic Diseases Centre under construction in Eldoret, Kenya.
